SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-22-236495
Filing Date
2022-09-01
Accepted
2022-09-01 16:02:50
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 d390847ds3.htm S-3 369507
2 EX-1.2 d390847dex12.htm EX-1.2 213026
3 EX-4.4 d390847dex44.htm EX-4.4 302603
4 EX-5.1 d390847dex51.htm EX-5.1 27750
5 EX-5.2 d390847dex52.htm EX-5.2 12902
6 EX-23.1 d390847dex231.htm EX-23.1 2450
7 EX-FILING FEES d390847dexfilingfees.htm EX-FILING FEES 44621
8 GRAPHIC g390847g04s40.jpg GRAPHIC 43627
9 GRAPHIC g390847g0830105121344.jpg GRAPHIC 1799
10 GRAPHIC g390847g0830105152562.jpg GRAPHIC 1799
11 GRAPHIC g390847g38g38.jpg GRAPHIC 66768
  Complete submission text file 0001193125-22-236495.txt   1131588
Mailing Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075
Business Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075 (858) 925-8215
eFFECTOR Therapeutics, Inc. (Filer) CIK: 0001828522 (see all company filings)

IRS No.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-267221 | Film No.: 221220973
SIC: 2834 Pharmaceutical Preparations